PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cullinan Therapeutics

Cullinan Therapeutics Reports the US FDA’s IND Approval of CLN-978 to Treat Systemic Lupus Erythematosus

Cullinan Therapeutics Reports the US FDA’s IND Approval of CLN-978 to Treat Systemic Lupus Erythematosus

October 16, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us